Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America as Represented by the Secretary, Dept. of Health and Human Services”

54 pharma patents match "The United States of America as Represented by the Secretary, Dept. of Health and Human Services" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 54
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 54 pharmaceutical patents matching "The United States of America as Represented by the Secretary, Dept. of Health and Human Services" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

54 results for “The United States of America as Represented by the Secretary, Dept. of Health and Human Services” · 30,257 patents in full index Clear search

  1. US 12298315

    Systems and methods to identify and treat subjects at risk for obstetrical complications

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted May 13, 2025 · Expires May 8, 2045

    granted
  2. US 12173306

    Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorders

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  3. US 12054519

    Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  4. US 11999747

    Furoquinolinediones as inhibitors of TDP2

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  5. US 11878004

    Method for inhibiting Zika virus infection

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  6. US 11802283

    Oligonucleotide analogues targeting human LMNA

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  7. US 11654147

    ALK2 inhibitors and methods for inhibiting BMP signaling

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted May 23, 2023 · Expires May 18, 2043

    granted
  8. US 11542261

    Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  9. US 11434268

    Vascular endothelial growth factor antagonists

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  10. US 11371024

    Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  11. US 11254667

    Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  12. US 11136372

    ApoC-II mimetic peptides

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted
  13. US 11078239

    Prefusion PIV F immunogens and their use

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  14. US 11052057

    Use of cysteamine and derivatives thereof to suppress tumor metastases

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  15. US 11026947

    ALK2 inhibitors and methods for inhibiting BMP signaling

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  16. US 10822608

    Oligonucleotide analogues targeting human LMNA

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  17. US 10767184

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  18. US 10538590

    Photosensitizing antibody-fluorophore conjugates

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted
  19. US 10350306

    Methods and compositions for treating genetically linked diseases of the eye

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  20. US 10351844

    Methods and compositions for treating leber congenital amaurosis

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  21. US 10300095

    AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted
  22. US 10227395

    Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted
  23. US 10188714

    Yeast-MUC1 immunotherapeutic compositions and uses thereof

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  24. US 10143721

    Combination product for the prevention of sexually transmitted infections

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted